- Áreas de investigación
-
- Biología y Biomedicina
- Grupo
-
- Proteómica, Genómica y Metabolómica
- Subgroup
-
- Proteómica
Quantification by competitive R5 ELISA
Service general data
- Support unit: PROTEOMICA
- Institute: CENTRO NACIONAL DE BIOTECNOLOGIA
- Locality: Madrid (Madrid)
- Service's web: http://www.cnb.csic.es/index.php/es/investigacion/servicios-cientificos/proteomica
Creado en 1999, el servicio de Proteómica del CNB mantiene una plataforma tecnológica para la identificación y caracterización masiva de proteínas, ofreciendo sus servicios tanto al CNB como a investigadores externos. El análisis masivo de proteínas (LC-MS/MS) se lleva a cabo mediante cromatografía nano-HPLC multidimensional acoplada a dos espectrómetros de masas modelo Thermo Orbitrap Explorios OE240 a un instrumento MALDI TOF/TOF MS. La proteómica diferencial o cuantitativa se realiza mediante previo marcaje isotópico estable, metabólico (SILAC) o químico (TMT) en combinación con análisis LC-MS/MS. Podemos realizar análisis dirigido PRM-MS (parallel reaction monitoring), y DIA (Data Independent Acquisition) . Enriquecimiento específico de modificaciones postraduccionales, particularmente fosfopéptidos, seguidos de análisis LC-MS/MS. Análisis de gluten en alimentos mediante la caracterización de prolamina.
Quantification by competitive R5 ELISA
Benefit description
Celiac disease is a permanent intolerance to prolamins of wheat, barley, rye and possibly also of oat. The ingestion of these proteins, in genetically predisposed people, induces a damage in the small intestine, characterized by crypt hyperplasia with total or subtotal villous atrophy and therefore interferes with absorption of nutrients from food. The incidence of celiac disease is approximately in the general population is 1 in 100-200, but recent evidence suggests that there are more undiagnosed than diagnosed cases. Presently, the only treatment for celiac disease is to follow a strict gluten-free diet for life. In our laboratory we use several techniques, both immunological (based on the R5 antibody) and non- immunological for the detection and quantification of gluten in foods. The immunological technique ELISA-R5 has been endorsed in 2006 by the Codex Alimentarius Commission as level I method for analysis of gluten in foods.| Options | Unit | Public Sector | Other customers |
|---|---|---|---|
| Analysis By Competitive R5-ELISA | muestra | 62.21 € | 68.14 € |
Other services
Service general data
- Support unit: PROTEÓMICA
- Institute: CENTRO DE BIOLOGIA MOLECULAR SEVERO OCHOA
- Locality: Madrid (Madrid)
- Service's web: http://www.cbm.uam.es/proteomica.htm
La investigación Proteómica implica la identificación y la caracterización de todo el perfil proteico de una célula, tejido u organismo, en un contexto espacial y temporal. El estudio incluye isoformas, mutantes, modificaciones e interacciones proteína-proteína/s. La trayectoria del Servicio de Proteómica ha sido paralela a la evolución de la comunidad científica, y sus objetivos son ofrecer soporte científico-técnico al investigador, con métodos apropiados para la preparación de la muestra y diseñando un flujo de trabajo para cada objetivo. Se utilizan todas las técnicas y equipamiento disponibles, se implementan mejoras en los protocolos, y se interpretan y analizan los resultados obtenidos. La cartera de servicios (a grupos del CBM-SO y a externos) es amplia, desde la confirmación de la secuencia de una proteína recombinante, a la cuantificación relativa de proteomas, la caracterización de modificaciones post-traduccionales y de mutaciones, de interactomas o la secuenciación De Novo
Quantification by competitive R5 ELISA
Benefit description
Celiac disease is a permanent intolerance to prolamins of wheat, barley, rye and possibly also of oat. The ingestion of these proteins, in genetically predisposed people, induces a damage in the small intestine, characterized by crypt hyperplasia with total or subtotal villous atrophy and therefore interferes with absorption of nutrients from food. The incidence of celiac disease is approximately in the general population is 1 in 100-200, but recent evidence suggests that there are more undiagnosed than diagnosed cases. Presently, the only treatment for celiac disease is to follow a strict gluten-free diet for life. In our laboratory we use several techniques, both immunological (based on the R5 antibody) and non- immunological for the detection and quantification of gluten in foods. The immunological technique ELISA-R5 has been endorsed in 2006 by the Codex Alimentarius Commission as level I method for analysis of gluten in foods.| Options | Unit | Public Sector | Other customers |
|---|---|---|---|
| Analysis By Competitive R5-ELISA | muestra | 62.21 € | 68.14 € |